Skip to main content

Table 1 Characteristics of the patient and the control group

From: Upregulation of CKIP-1 inhibits high-glucose induced inflammation and oxidative stress in HRECs and attenuates diabetic retinopathy by modulating Nrf2/ARE signaling pathway: an in vitro study

 

Control (n = 10)

Diabetic cataract (n = 20)

P value

Age (years)

66.70 ± 4.85

70.5 ± 5.31

0.068

Gender (male/female)

7/3

12/8

0.592

Fasting blood glucose (mmol/l)

5.35 ± 0.15

8.01 ± 0.67

< 0.001